These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21450587)

  • 1. Implementation of a pharmacist-led intervention to enhance statin prescribing for secondary prevention in primary care: a cluster randomized trial.
    van de Steeg-van Gompel CH; Wensing M; De Smet PA
    Eur J Prev Cardiol; 2012 Apr; 19(2):169-76. PubMed ID: 21450587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of educational outreach to improve evidence-based prescribing in Medicaid: a cautionary tale.
    Zillich AJ; Ackermann RT; Stump TE; Ambuehl RJ; Downs SM; Holmes AM; Katz B; Inui TS
    J Eval Clin Pract; 2008 Oct; 14(5):854-60. PubMed ID: 19018918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An intervention to improve secondary prevention of coronary heart disease.
    Bailey TC; Noirot LA; Blickensderfer A; Rachmiel E; Schaiff R; Kessels A; Braverman A; Goldberg A; Waterman B; Dunagan WC
    Arch Intern Med; 2007 Mar; 167(6):586-90. PubMed ID: 17389290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community Pharmacists Assisting in Total Cardiovascular Health (CPATCH): A Cluster-Randomized, Controlled Trial Testing a Focused Adherence Strategy Involving Community Pharmacies.
    Blackburn DF; Evans CD; Eurich DT; Mansell KD; Jorgenson DJ; Taylor JG; Semchuk WM; Shevchuk YM; Remillard AJ; Tran DA; Champagne AP
    Pharmacotherapy; 2016 Oct; 36(10):1055-1064. PubMed ID: 27581815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cluster randomised controlled trial of a pharmacist-led collaborative intervention to improve statin prescribing and attainment of cholesterol targets in primary care.
    Lowrie R; Lloyd SM; McConnachie A; Morrison J
    PLoS One; 2014; 9(11):e113370. PubMed ID: 25405478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacist-to-prescriber intervention to close therapeutic gaps for statin use in patients with diabetes: A randomized controlled trial.
    Renner HM; Hollar A; Stolpe SF; Marciniak MW
    J Am Pharm Assoc (2003); 2017; 57(3S):S236-S242.e1. PubMed ID: 28506378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a global risk educational tool on primary coronary prevention: the Atherosclerosis Assessment Via Total Risk (AVIATOR) study.
    Jacobson TA; Gutkin SW; Harper CR
    Curr Med Res Opin; 2006 Jun; 22(6):1065-73. PubMed ID: 16846539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arriba: effects of an educational intervention on prescribing behaviour in prevention of CVD in general practice.
    Keller H; Krones T; Becker A; Hirsch O; Sönnichsen AC; Popert U; Kaufmann-Kolle P; Rochon J; Wegscheider K; Baum E; Donner-Banzhoff N
    Eur J Prev Cardiol; 2012 Jun; 19(3):322-9. PubMed ID: 21450565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial assessing the impact of a personal printed feedback portrait on statin prescribing in primary care.
    Dormuth CR; Carney G; Taylor S; Bassett K; Maclure M
    J Contin Educ Health Prof; 2012; 32(3):153-62. PubMed ID: 23008077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of pharmacist-initiated interventions in improving acute coronary syndrome secondary prevention pharmacotherapy prescribing upon discharge.
    Hassan Y; Kassab Y; Abd Aziz N; Akram H; Ismail O
    J Clin Pharm Ther; 2013 Apr; 38(2):97-100. PubMed ID: 23441979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cluster randomised controlled trial of pharmacist led statin outreach support (SOS) in primary care: design and baseline characteristics.
    Lowrie R; Morrison J; McConnachie A
    Contemp Clin Trials; 2010 Jul; 31(4):303-11. PubMed ID: 20348032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-focused intervention to improve long-term adherence to evidence-based medications: a randomized trial.
    Calvert SB; Kramer JM; Anstrom KJ; Kaltenbach LA; Stafford JA; Allen LaPointe NM
    Am Heart J; 2012 Apr; 163(4):657-65.e1. PubMed ID: 22520532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A qualitative study of barriers to the use of statins and the implementation of coronary heart disease prevention in primary care.
    Kedward J; Dakin L
    Br J Gen Pract; 2003 Sep; 53(494):684-9. PubMed ID: 15103875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community pharmacist-led intervention to identify persons with diabetes not on statin therapy.
    Drake ES; Harris DK; Marciniak MW
    J Am Pharm Assoc (2003); 2018; 58(4S):S125-S130. PubMed ID: 30006183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lifestyle or life-saving medicines? A primary healthcare professional and consumer opinion survey on over-the-counter statins.
    Vamvakopoulos JE; Kountouri M; Marshall T; Greenfield SM
    Ann Pharmacother; 2008 Mar; 42(3):413-20. PubMed ID: 18303145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Missed opportunities in the secondary prevention of myocardial infarction: an assessment of the effects of statin underprescribing on mortality.
    Austin PC; Mamdani MM; Juurlink DN; Alter DA; Tu JV
    Am Heart J; 2006 May; 151(5):969-75. PubMed ID: 16644313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of embedded versus remote pharmacist versus remote student pharmacist outreach on statin prescribing.
    Hayes M; Gregory P; Smith B; Champagne B; Patel A; Alvarado H; Roberson C; Yang C; Lee HJ; Erkanli A
    J Am Pharm Assoc (2003); 2024; 64(4S):102127. PubMed ID: 38796162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of a discontinuation letter to reduce long-term benzodiazepine use--a cluster randomized trial.
    van de Steeg-van Gompel CH; Wensing M; De Smet PA
    Drug Alcohol Depend; 2009 Jan; 99(1-3):105-14. PubMed ID: 18801626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
    Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
    Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient and other factors influencing the prescribing of cardiovascular prevention therapy in the general practice setting with and without nurse assessment.
    Mohammed MA; El Sayed C; Marshall T
    Med Decis Making; 2012; 32(3):498-506. PubMed ID: 22357626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.